The age of the
mind-machine
is here.
The future of consciousness, tracked daily.
Neurotechnology is rewriting what it means to be human — and what it means to be intelligent. We track the companies, breakthroughs, and ideas at this frontier, so you don't miss a moment of the most important shift in the history of mind.
758+
Companies tracked
across 9 categories
$18B+
VC invested
in the field globally
132+
Articles published
research & industry
Every Sunday
Weekly digest
NeuroTech Digest
"The question is no longer whether machines can think —
but whether they can learn to love."
Browse by category
View all 758 companies →Featured companies
Kernel
Research Tools
Kernel builds non-invasive neuroimaging helmets — the Flow (TD-fNIRS) and Flux (MEG) systems — designed to make high-resolution brain scanning accessible outside of hospital settings. Founded by Bryan Johnson, the company aims to democratize neuroscience research and brain measurement at scale.
MindMed
Psychedelics
MindMed is a clinical-stage psychedelic medicine company developing novel therapeutics derived from LSD, MDMA, and ibogaine analogs for neurological and psychiatric disorders. Their lead asset MM120 (LSD tartrate) has shown promising Phase 2b results for generalized anxiety disorder.
Recently added
Funding spotlight
ATLAS Neuroengineering
Private
Blackrock Neurotech
Private
ClearPoint Neuro, Inc.
Private
COGNOTICA
Private
Deep Sleep Technologies
Private
DIXI medical
Private
Latest news
Paradromics has received FDA approval to embed its brain-computer interface software directly into personal consumer devices.
MIT Media Lab has launched a project exploring brain-computer interfaces designed to function across interstellar distances.
China has unveiled the world's first full-stack MRI-based BCI solution, claiming to make neural plasticity both measurable and controllable.
A new brain implant leverages infrared light rather than electrical current to transmit neural signals, potentially overcoming key BCI hardware constraints.
FDA clears BlueWind Medical's Revi Extend neuromodulation implant, doubling device longevity to 15 years for patients.
The global neurofeedback systems market is projected to reach $2.95 billion by 2035, signaling sustained investment across clinical and consumer segments.
Compact neuromodulation devices are entering the market, forcing traditional TMS providers to rethink their clinical and business models.
A brain-computer device has helped a man regain the ability to speak, according to a new report from the National Institutes of Health.
Every Sunday
The NeuroTech Digest
Funding rounds, breakthroughs, and top jobs — curated weekly for industry professionals.
Subscribe free →For companies
Reach neurotech decision-makers
Premium listings, newsletter sponsorships, and featured placements.
View packages →News & insights
All articles →
PolicyParadromics Wins FDA Approval to Embed BCI Software in Personal Devices
Paradromics has received FDA approval to embed its brain-computer interface software directly into personal consumer devices.
2026-08-26
ResearchMIT Media Lab Sets Its Sights on Brain-Computer Interfaces Beyond Earth
MIT Media Lab has launched a project exploring brain-computer interfaces designed to function across interstellar distances.
2026-08-25
ResearchChina Launches World's First Full-Stack MRI-Based BCI Solution, Promising Measurable Neural Plasticity
China has unveiled the world's first full-stack MRI-based BCI solution, claiming to make neural plasticity both measurable and controllable.
2026-08-24
ResearchBrain Implant Uses Infrared Light to Bypass Electrode Limitations in Neural Signaling
A new brain implant leverages infrared light rather than electrical current to transmit neural signals, potentially overcoming key BCI hardware constraints.
2026-08-23
ProductBlueWind Medical's Revi Extend Wins FDA Clearance, Extending Implant Life to 15 Years
FDA clears BlueWind Medical's Revi Extend neuromodulation implant, doubling device longevity to 15 years for patients.
2026-08-06
IndustryNeurofeedback Systems Market Eyes $2.95 Billion Valuation by 2035 as Clinical and Consumer Demand Converge
The global neurofeedback systems market is projected to reach $2.95 billion by 2035, signaling sustained investment across clinical and consumer segments.
2026-08-05
The field, by the numbers
758+
Companies mapped
across 9 sectors
$18B+
VC invested
in the field globally
3×/week
News published
Mon · Wed · Fri
44+
Articles
research & industry
Companies by sector
22
Brain-Computer
13
Cognitive
29
Mental
37
Neuromodulation
33
Neuropharmaceuticals
20
Neurodiagnostics
11
Research
13
Neurofeedback
39
Psychedelics
The NeuroTech Digest
The signal through the noise — breakthroughs, funding, and ideas at the edge of mind and machine. Curated weekly.
No spam. Unsubscribe anytime.